Erste Group Bank Increases Earnings Estimates for CME Group

Posted by Brian Himes on Jun 11th, 2026

CME Group Inc. (NASDAQ:CME – Free Report) – Analysts at Erste Group Bank raised their FY2026 EPS estimates for CME Group in a research note issued on Friday, June 5th. Erste Group Bank analyst H. Engel now expects that the financial services provider will post earnings per share of $12.24 for the year, up from their prior estimate of $12.21. Erste Group Bank has a “Hold” rating on the stock. The consensus estimate for CME Group’s current full-year earnings is $12.28 per share.

CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating the consensus estimate of $3.11 by $0.25. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.80 earnings per share.

Other research analysts also recently issued reports about the company. Morgan Stanley dropped their price target on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research note on Thursday, April 23rd. Raymond James Financial boosted their price objective on CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a report on Monday, April 6th. Rothschild & Co Redburn lowered their target price on CME Group from $340.00 to $316.00 and set a “neutral” rating on the stock in a research report on Monday, April 27th. TD Cowen cut their target price on CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Finally, JPMorgan Chase & Co. lifted their price target on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research report on Thursday, April 16th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $305.29.

Read Our Latest Research Report on CME Group

CME Group Stock Performance

Shares of CME opened at $263.80 on Thursday. CME Group has a one year low of $244.56 and a one year high of $329.16. The company has a market cap of $95.59 billion, a PE ratio of 22.51, a P/E/G ratio of 2.86 and a beta of 0.21. The stock has a 50-day moving average of $286.00 and a 200-day moving average of $288.28. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is currently 44.37%.

Insider Activity

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares in the company, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 44,044 shares of company stock worth $13,297,507 over the last 90 days. 0.30% of the stock is currently owned by corporate insiders.

Institutional Trading of CME Group

Institutional investors and hedge funds have recently made changes to their positions in the company. West Family Investments Inc. boosted its holdings in CME Group by 1.2% during the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 37 shares during the last quarter. Asset Dedication LLC increased its stake in CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares during the last quarter. Northwestern Mutual Investment Management Company LLC increased its stake in CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after buying an additional 37 shares during the last quarter. Rehmann Capital Advisory Group lifted its position in shares of CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after buying an additional 37 shares in the last quarter. Finally, 1248 Management LLC lifted its position in shares of CME Group by 26.8% during the 3rd quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock worth $49,000 after buying an additional 38 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME Group launched Nasdaq CME Crypto Index futures, a regulated cash-settled product tied to a benchmark of major cryptocurrencies including Bitcoin, Solana, XRP and others. The new offering could attract more trading volume from investors seeking broad crypto exposure and hedging tools. Article Title
Positive Sentiment: CME Group and Morningstar announced an exclusive multi-year licensing agreement to launch derivatives based on Morningstar equity index benchmarks, opening a new product line tied to indexes that underpin more than $3 trillion in linked assets. Article Title
Positive Sentiment: Shareholders maintained CME’s Class B governance structure and rejected a bid to end those director election rights, removing a potential governance overhang and preserving the company’s current control framework. Article Title
Neutral Sentiment: CME also announced its second-quarter 2026 earnings release date for July 22, which is mainly a scheduling update but keeps attention on upcoming results. Article Title
Neutral Sentiment: Reports about short interest and options activity suggest traders are watching CME closely, but those items do not yet point to a clear fundamental catalyst. Article Title

CME Group Company Profile

(Get Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.